The Pharmaceutical Company
Efficency Gap
Manual processes are costing pharmaceutical companies millions in delayed launches.
While market opportunities emerge in real-time, pharmaceutical marketing operates at the speed of manual analysis and lengthy review cycles. This efficiency gap directly impacts time-to-market and revenue.
65%
of pharma content never reaches its intended audience (DeepIntent)
20+
days average MLR review per piece
(Veeva Content Metrics 2023)
37
hours weekly spent on manual analysis per team
$24M
lost for each month a drug's market entry is postponed (Tufts CSDD)
MEET BRIANN: YOUR PHARMACEUTICAL AI
MARKETING TEAM
Purpose-built to find audience insight and generate best in class data-driven, compliant content
BRIANN (Buzz Radar Insight Analyst Neural Network) combines audience intelligence, deep content understanding, and compliance expertise into a single AI team for pharmaceutical companies.
Trained on 40+ million healthcare conversations, BRIANN transforms into your expert pharmaceutical marketing team:
AUDIENCE ANALYST
Deep insights into HCP and patient conversations
INFLUENCER MAPPER
DOL identification, curation and engagement strategies
DATA DRIVEN STRATIGIST
campaign optimisation and competitive intelligence
COMPETITOR SCOUT
Monitor competitor online activity and perception with their audience.
DASHBOARD BUILDER
Custom analytics and reporting views
COMPLIANCE SPECIALIST
Automated MLR support and regulatory guidance
90-DAY EVALUATION OPTION
For organisations ready to test the impact of AI pharmaceutical marketing intelligence
FULL PLATFORM & AI AGENT ACCESS
40% higher engagement rates
on social content
DEDICATED SUPPORT
85% greater audience targeting accuracy
REAL-WORLD APPLICATION
Increased fan loyalty
and advocacy
SEAMLESS TRANSITION
32% better sponsorship effectiveness
PROVEN IMPACT ON PHARMACEUTICAL
MARKETING SPEED
Leading pharmaceutical companies are dramatically accelerating their marketing operations with AI
AI-ACCELERATED COMPLIANCE WORKFLOWS
Your AI team is trained on ABPI, EFPIA, MHRA, PhRMA and JPMA guidelines to accelerate review cycles
How Your AI Team Accelerates Compliance
Data Driven Content Suggestions
Real-time audience insights ensure optimised content prior to review
Provides instant MLR content review
Issues are clearly listed with their impact on guidelines specified
Check any content across multiple guidelines
Compliance is maintained with both external codes and internal guidelines
Review audio, images and video as well as text
BRIANN can watch videos and listen to podcasts to verify compliance across all formats.
TRADITIONAL MLR REVIEW
DAYS AVERAGE
WITH YOUR AI TEAM
DAYS AVERAGE
Note: Single compliance remediation averages $4.35 million (IBM/Ponemin Institute 2023) - Your AI team helps prevent issues before they occur
HUMAN IN THE LOOP MONITORING
BRIANN combines AI capabilities with human pharmaceutical expertise to maintain the highest standards
EXPERT VALIDATION AT EVERY STEP
While other AI solutions operate as black boxes, BRIANN provides transparent, human-verified insights with pharmaceutical specialists maintaining oversight at every step.
ENTERPRISE-GRADE SECURITY & COMPLIANCE
Deploy BRIANN within your existing infrastructure. No patient or proprietary data ever leaves your secure environment.
ENTERPRISE-GRADE SECURITY & COMPLIANCE
-
✔Compliance Accuracy:
Human experts verify AI-generated recommendations -
✔Quality Assurance:
Multiple verification checkpoints before delivery -
✔Medical Accuracy:
Scientific medical experts review critical content -
✔Audit-Ready Outputs:
Complete documentation of decision processes